Success Metrics

Clinical Success Rate

90.9%

Based on 10 completed trials

Completion Rate

91%(10/11)

Active Trials

0(0%)

Results Posted

30%(3 trials)

Terminated

1(9%)

Phase Distribution

Ph not_applicable

18%

Ph phase_2

27%

Ph phase_3

36%

Ph phase_4

18%

Phase Distribution

Early Stage

Mid Stage

Late Stage

Phase Distribution11 total trials

Phase 2Efficacy & side effects

3(27.3%)

Phase 3Large-scale testing

4(36.4%)

Phase 4Post-market surveillance

2(18.2%)

N/ANon-phased studies

2(18.2%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

90.9%

10 of 11 finished

Non-Completion Rate

9.1%

1 ended early

Currently Active

trials recruiting

Total Trials

all time

Status Distribution

Completed(10)

Terminated(1)

Detailed Status

Completed10

Terminated1

Development Timeline

Analytics

Development Status

Total Trials

Active

Success Rate

90.9%

Most Advanced

Phase 4

Trials by Phase

Phase 23 (27.3%)

Phase 34 (36.4%)

Phase 42 (18.2%)

N/A2 (18.2%)

Trials by Status

completed1091%

terminated19%

Recent Activity

0 active trials

Showing 5 of 11

completedphase_4

A Comparative Study of ASP1585 in Chronic Kidney Disease Patients With Hyperphosphatemia on Hemodialysis

NCT01057407

View all 11 trials

Clinical Trials (11)

Showing 11 of 11 trials

NCT03451019Phase 4

Different Effects of Non-calcium Phosphate Binders on Serum Calcium

Completed

NCT00441545Phase 3

Head to Head Study Against Sevelamer Hydrochloride

Completed

NCT00745589Not Applicable

Sevelamer Hydrochloride in Peritoneal Dialysis Patients

Completed

NCT01850602Phase 3

A Phase III Study of PA21 in Hemodialysis Patients With Hyperphosphatemia

Completed

NCT01057407Phase 3

A Comparative Study of ASP1585 in Chronic Kidney Disease Patients With Hyperphosphatemia on Hemodialysis

Completed

NCT00324571Phase 4

Dialysis Clinical Outcomes Revisited (DCOR) Trial

Completed

NCT00324376Phase 2

Study to Compare Once A Day Sevelamer Dosing With Three Times Per Day Sevelamer Dosing

Completed

NCT00824460Phase 2

Study of Phosphate Levels in Patients With Chronic Kidney Disease

Completed

NCT00505037Phase 2

A Phase 2 Study of ASP1585 in Chronic Kidney Disease Patients With Hyperphosphatemia on Hemodialysis

Completed

NCT00844662Phase 3

Phase III Study to Investigate the Safety and Efficacy of Fermagate and Sevelamer Hydrochloride

Terminated

NCT01049815Not Applicable

Sevelamer Hydrochloride and Femoral and Carotid Intima Media Thickness Progression in End Stage Renal Disease

Completed

All 11 trials loaded

Drug Details

Intervention Type: DRUG
Total Trials: 11